X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Botulinum Toxin Companies (2024 - 2029)

Several companies in the pharmaceutical industry are making significant strides in their respective fields. These corporations, which range from those specializing in therapeutics to others focusing on the development of new drugs, are making a significant impact on the healthcare sector. With their innovative approaches, these firms are shaping the future of medicine, demonstrating the critical role companies play in advancing healthcare.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research Synthetic Compounds Research Botox Industry Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in Botulinum Toxin Market

This report lists the top Botulinum Toxin companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Botulinum Toxin industry.

  1. Evolus

  2. Abbvie

  3. Merz Pharma

  4. Ipsen

  5. Galderma

*Disclaimer: Top companies sorted in no particular order

Botulinum Toxin Market Major Players

Botulinum Toxin Market Concentration

Botulinum Toxin Market Concentration

Botulinum Toxin Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Demand for Aesthetic Procedures

      2. 4.2.2 Growing Research and Development Initiatives to Expand the Therapeutic Applications of Botulinum Toxin

    3. 4.3 Market Restraints

      1. 4.3.1 Adverse Effects Associated with Botulinum Toxin

      2. 4.3.2 Lack of Reimbursement Policies Supporting Cosmetic Procedures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 5.1 By Application

      1. 5.1.1 Cosmetic Applications

        1. 5.1.1.1 Glabellar Lines

        2. 5.1.1.2 Lateral Canthal Lines (Crow's Feet)

        3. 5.1.1.3 Forehead Lines

        4. 5.1.1.4 Other Cosmetic Applications

      2. 5.1.2 Non-cosmetic Applications

        1. 5.1.2.1 Dystonia

        2. 5.1.2.2 Chronic Migraine

        3. 5.1.2.3 Ophthalmologic Disorders

        4. 5.1.2.4 Other Non-cosmetic Applications

    2. 5.2 By End User

      1. 5.2.1 Spas and Beauty Centers

      2. 5.2.2 Clinics and Hospitals

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Merz Pharma GmbH & Co. KGaA

      2. 6.1.2 AbbVie Inc. (Allergan)

      3. 6.1.3 Evolus Inc.

      4. 6.1.4 Revance Therapeutics Inc. (Revance Aesthetics)

      5. 6.1.5 HUGEL

      6. 6.1.6 Ipsen Biopharmaceuticals Inc.

      7. 6.1.7 USWM LLC

      8. 6.1.8 Medytox

      9. 6.1.9 Eisai

      10. 6.1.10 Hughs

      11. 6.1.11 Galderma

      12. 6.1.12 Daewoong Pharmaceuticals

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to Botulinum Toxin Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Botulinum Toxin Market Companies Summary

The botulinum toxin sector is characterized by moderate fragmentation due to the presence of numerous market players. The competitive landscape encompasses an analysis of several international as well as local firms that hold significant market shares. Major firms in the market include a variety of pharmaceutical and biotech companies, among others. These companies have been instrumental in driving the growth of the botulinum toxin market through their research and development initiatives, product launches, and clinical trials. The impact of COVID-19 on the market was significant, largely due to the reduction of botulinum toxin procedures following the imposition of strict lockdown restrictions. However, with the relaxation of guidelines on non-elective aesthetic procedures in the post-pandemic period, companies are expected to witness growth over the coming years. Factors such as increasing demand for aesthetic procedures, growing patient preference for non-invasive treatments, and novel product development are driving the growth of the market. Furthermore, the therapeutic usage of botulinum toxin in various non-cosmetic procedures is expected to contribute to market growth.

Explore More

Botulinum Toxin Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 Merz Pharma GmbH & Co. KGaA

      2. 1.1.2 AbbVie Inc. (Allergan)

      3. 1.1.3 Evolus Inc.

      4. 1.1.4 Revance Therapeutics Inc. (Revance Aesthetics)

      5. 1.1.5 HUGEL

      6. 1.1.6 Ipsen Biopharmaceuticals Inc.

      7. 1.1.7 USWM LLC

      8. 1.1.8 Medytox

      9. 1.1.9 Eisai

      10. 1.1.10 Hughs

      11. 1.1.11 Galderma

      12. 1.1.12 Daewoong Pharmaceuticals

    2. *List Not Exhaustive

Botulinum Toxin Companies FAQs

Evolus, Inc., AbbVie Inc. (Allergan), Merz Pharma GmbH & Co. KGaA, Ipsen Pharma and Galderma are the major companies operating in the Botulinum Toxin Market.

Botulinum Toxin Market Report Snapshots

Botulinum Toxin Market Overview - Industry Analysis, Size & Forecast Report (2024 - 2029)